Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
618.00    5.00 (0.82%)
Bid:
617.00
Ask:
619.00
Spread: 2.00 (0.324%)
Market Cap: £685.83m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

1 Feb 2018 07:00

RNS Number : 5489D
Barr(A.G.) PLC
01 February 2018
 

 

 

1 February 2018

A.G. BARR p.l.c.

("A.G. BARR")

Trading Update

 

A.G. BARR p.l.c., which produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the financial year ended 27 January 2018.

 

Total revenue for the 52 weeks ended 27 January 2018 is expected to be c.£277m, up c.7.5% on the prior year (2017 : £257.1m).

 

This positive revenue performance reflects the continued success of our innovation alongside strong trading execution across our core brands. It is pleasing that we have continued to outperform the total UK soft drinks market and increased our overall market share. Latest IRI available Marketplace data for the 48 weeks to 31 December 2017 saw the market value up 2.7% and volume broadly flat.

 

Since our announcement in March 2017 that over 90% of our portfolio would be moving to lower or no sugar, we have extended our innovation and reformulation programme such that we now expect that up to 99% of our portfolio will contain less than 5g of total sugars per 100ml before the implementation of the soft drinks sugar tax in April this year.

 

As anticipated, the sugar reduction in regular IRN-BRU in early January 2018 was met with widespread media interest. Our extensive research and testing in the preceding years gave us confidence that we had an excellent taste match and, whilst it is still early days, the consumer response to the new product has so far been encouraging.

 

Our balance sheet remains robust, supported by strong free cash flow, and we have continued to invest across the business while also progressing the share repurchase programme we announced in March 2017.

 

We have not been immune to the external cost pressures faced by many businesses throughout 2017, particularly in relation to the weakness of sterling, however we remain confident of delivering profit growth for the year in line with our expectations.

 

Outlook

It is expected that 2018 will be another challenging year for UK businesses against a backdrop of continued uncertain economic conditions. In addition the soft drinks industry faces significant changes in regulation, customer dynamics and consumer preferences, bringing both challenges and opportunities. We believe that our strong and flexible business model, our portfolio of brands which reflect the requirements of today's consumer, and our exciting innovation pipeline, ensure we remain well placed to capitalise on opportunities to grow our business and deliver long-term value to shareholders.

 

A.G. BARR intends to announce its full year financial results on 27 March 2018.

 

For further information, please contact:

A.G. BARR Tel: 01236 852400 Roger White, Chief Executive

Stuart Lorimer, Finance Director

Instinctif Partners Tel: 020 7457 2020 Justine Warren

Matthew Smallwood

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTWGUQWGUPRGMG
Date   Source Headline
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding
10th Feb 20253:59 pmRNSDirector/PDMR Shareholding - Replacement
10th Feb 20253:10 pmRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSTrading Update
20th Jan 202511:00 amRNSDirector Declaration
9th Jan 20254:42 pmRNSDirector/PDMR Shareholding
7th Jan 202511:44 amRNSNotice of Trading Update
17th Dec 20249:20 amRNSDirector Declaration
9th Dec 20241:50 pmRNSDirector/PDMR Shareholding
12th Nov 20241:35 pmRNSDirector/PDMR Shareholding
4th Nov 202410:54 amRNSDirector/PDMR Shareholding
9th Oct 202410:10 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSInterim Results
9th Sep 20241:03 pmRNSDirector/PDMR Shareholding
4th Sep 20249:08 amRNSDirector Declaration
20th Aug 20248:39 amRNSDirector/PDMR Shareholding
8th Aug 20241:10 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTrading Statement
8th Jul 202412:03 pmRNSDirector/PDMR Shareholding
4th Jul 202410:17 amRNSNotice of Results
1st Jul 20244:50 pmRNSDirector/PDMR Shareholding
21st Jun 20243:22 pmRNSDirector/PDMR Shareholding
10th Jun 20241:51 pmRNSDirector/PDMR Shareholding
10th Jun 20241:48 pmRNSDirector/PDMR Shareholding
4th Jun 20249:36 amRNSDirector/PDMR Shareholding
31st May 20241:54 pmRNSResult of AGM
9th May 202411:28 amRNSDirector/PDMR Shareholding
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.